Etusivu » Finnish Medical Journal » English summaries

English summaries

Fatal poisonings in Finland during 2008–2010
Julkaistu 01.06.2012 00.01

At the beginning of 2010, the organization of medicolegal cause-of-death investigations changed in Finland. Forensic pathologists moved from a province-based system to a new system of central organization under the National Institute for Health and Welfare. The rate of forensic autopsies has remained high, at 24% of all deaths, i.e. about 12,000 autopsies annually. Post mortem forensic toxicological investigations are centralized at the Hjelt Institute, University of Helsinki. The number of post mortem toxicological investigations has increased, and in 2010 these cases numbered 7,105, covering approximately 14% of all deaths and 60% of all forensic autopsies. Apart from a 2-year-old girl who died of carbon monoxide poisoning in a fire, there were no accidental fatal poisonings in children in 2008–2010.

The numbers of fatal poisonings detected during the period 2008–2010 were 1,213, 1,211 and 1,048, respectively. The exceptionally low number in 2010 was due to a decrease in the numbers of both alcohol poisonings and drug poisonings. However, opioids maintained their major position. The consumption of alcohol, especially spirits, declined. Looking at drug-related deaths in relation to drug consumption, the most dangerous medicine in Finland was by far levomepromazine (methotrimeprazine), followed by the two antidepressants mirtazapine and doxepin. Opioid deaths involved buprenorphine, tramadol, codeine, fentanyl, methadone or oxycodone, and typically involved abuse. Buprenorphine was the most abused opioid in Finland. Heroin and cocaine were found only 1–2 times annually. The most common designer drug was methylenedioxypyrovalerone (MDPV), which was detected for the first time in 2009.

In the long term, carbon monoxide fatalities have declined, mainly due to the falling number of suicides involving car exhaust gas. The total number of carbon monoxide suicides during the three study years was 41, compared with 50 such cases in 1998 alone.

Erkki Vuori, M.D., Ph.D., M.Sc., Professor Emeritus, E-mail: erkki.o.vuori@helsinki.fi

Ilkka Ojanperä, Ph.D., Professor

Terhi Launiainen, Ph.D., Postdoctoral Researcher

Jari Nokua, M.Sc., Forensic Toxicologist

Riitta-Leena Ojansivu, M.Sc., Forensic Toxicologist

Hjelt Institute, University of Helsinki

Finnish Medical Journal 2012;67:1735–41.

 

Previous Next More news  
Käynnistä keskustelu aiheesta Kerro kollegalle Tulosta

Kerro kollegalle

Lähetä uutinen sähköpostilla


Uusimmat uutiset

Physicians’ experience of the adequacy of tuition in evidence-based medicine in medical studies 17.05.2013

Cildren presenting with joint pain17.05.2013

Gender differences in mental health17.05.2013

The MUMM programme and cooperation within specific catchment areas10.05.2013

Effectiveness in pharmacoeconomic research10.05.2013

Treatments for rheumatoid arthritis are evolving, what about the long-term prognosis?10.05.2013

Arthralgia due to diabetes and other endocrinological diseases03.05.2013

Current and future needs for hospital treatment of pneumonia03.05.2013

Measurement of health-related quality of life 26.04.2013

Economic evaluation of health care26.04.2013

Suomen Lääkärilehti
Mäkelänkatu 2, PL 49, 00501 Helsinki
Puh. (09) 393 091, Fax (09) 393 0794
laakarilehti@laakarilehti.fi
© Suomen Lääkärilehti 1998-2013